New target for chronic inflammation in colorectal cancer
IGF-1 activated by p38 may be a therapeutic target
List view / Grid view
News
Malaria vaccine targets PMIF
A new malaria vaccine targets the protein PMIF, which is crucial in the life cycle of malaria parasites...
Study identifies potential therapy for a common cause of dementia
Early-stage research has uncovered a potential approach to treat one of the commonest causes of dementia and stroke in older people...
Epidemiologists highlight a link between Alzheimer’s and herpes
A new commentary by epidemiologists supports the viability of a potential way to reduce the risk of Alzheimer's disease...
Discovery of statistical method identifies cancer predisposition
New statistical method, ALFRED, could identify predisposition for cancers by using cancer genome data sets to identify risk variants.
Injected VEGF-C could prevent heart failure
Vascular Endothelial Growth Factor C (VEGF-C) could aid the repair and recovery of hearts after a heart attack, by enabling immune cells to clear dead and dying cells...
3D map of CVD genetic interactions could aid future treatments
A 3D map of genetic interactions in CVD could aid researchers investigating future treatments for heat attacks, heart failure and heart rhythm disorders.
Study pinpoints the ‘Big Bang’ of tau-induced Alzheimer’s neurodegeneration
Scientists in the U.S. have identified what they believe to be the genesis of Alzheimer's disease – the precise point at which a healthy tau protein becomes toxic but has not yet formed deadly tangles in the brain. The finding opens up numerous avenues for treatment research.
Brain cancer with mutation at EGFR alanine 289 may be susceptible to monoclonal antibody mAb806
Antibody mAb806 may be useful in treating aggressive forms of glioblastoma multiform...
MedImmune expert speaker interview released in run up to Immuno-Oncology Conference
Exclusive interview with Grace Macaulay - MedImmune released in the run up to the Immuno-Oncology Conference, taking place on the 26 - 27 September 2018 in London.
New insight into Huntington’s disease may open door to drug development
Researchers have developed a new theory on Huntington's disease which is being welcomed for showing promise to open new avenues of drug development for the condition...
PNA gene editing technique cures beta-thalassemia in utero
Researchers have for the first time used a gene editing technique to successfully cure a genetic condition in a mouse model...
New targets found to reduce blood vessel damage in diabetes
Researchers identify new treatment targets for diseases associated with endothelial cell senescence, or ageing, such as diabetes, cardiovascular disease and age-related disorders...
How does Parkinson’s disease develop?
Study raises doubts on a previous theory of Parkinson’s disease...
New software designed for rapid, automated identification of dendritic spines
Researchers release open source software, connecting and building the neuroscience coding community...
